Methylprednisolone and Visual field defect - a phase IV clinical study of FDA data
Summary:
Visual field defect is reported as a side effect among people who take Methylprednisolone (methylprednisolone), especially for people who are female, 30-39 old, have been taking the drug for < 1 month also take Mycophenolate Mofetil, and have High blood pressure.
The phase IV clinical study analyzes which people have Visual field defect when taking Methylprednisolone. It is created by eHealthMe based on reports of 58,374 people who have side effects when taking Methylprednisolone from the FDA, and is updated regularly.
What is Methylprednisolone?
Methylprednisolone has active ingredients of methylprednisolone. It is often used in inflammation. eHealthMe is studying from 59,645 Methylprednisolone users. Check the latest studies of Methylprednisolone.
What is Visual field defect?
Visual field defect is found to be associated with 766 drugs and 1,038 conditions by eHealthMe. Check the latest studies of Visual field defect.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
58,374 people reported to have side effects when taking Methylprednisolone.
Among them, 64 people (0.11%) have Visual field defect.

Among these 64 people:
How long have people been on Methylprednisolone when they have Visual field defect? *
- < 1 month: 100 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Visual field defect when taking Methylprednisolone? *
- female: 60.71 %
- male: 39.29 %
What is the age of people who have Visual field defect when taking Methylprednisolone? *
- 0-1: 0.0 %
- 2-9: 14.29 %
- 10-19: 2.38 %
- 20-29: 0.0 %
- 30-39: 38.1 %
- 40-49: 21.43 %
- 50-59: 0.0 %
- 60+: 23.81 %
What are other drugs people take besides Methylprednisolone? *
- Mycophenolate Mofetil: 18 people, 28.12%
- Prograf: 17 people, 26.56%
- Prednisone: 16 people, 25.00%
- Tacrolimus: 15 people, 23.44%
- Lamivudine: 12 people, 18.75%
- Ranitidine: 12 people, 18.75%
- Ramipril: 12 people, 18.75%
- Zoledronic Acid: 11 people, 17.19%
- Dexamethasone: 11 people, 17.19%
- Ondansetron: 11 people, 17.19%
What are other side effects people have besides Visual field defect? *
- Headache (pain in head): 20 people, 31.25%
- Optic Atrophy (the loss of a proportion of optic disc nerve fibres): 16 people, 25.00%
- Toxic Optic Neuropathy (optic nerve damage caused by toxic (harmful) substances): 13 people, 20.31%
- Hypertriglyceridaemia (excess of triglycerides in the blood): 12 people, 18.75%
- Optic Nerve Disorder (disease of optic nerve): 12 people, 18.75%
- Complications Of Transplanted Kidney: 12 people, 18.75%
- Toxic Neuropathy (nerve damage caused by toxic (harmful) substances): 12 people, 18.75%
- Hyperthyroidism (over activity of the thyroid gland): 12 people, 18.75%
- Anaemia (lack of blood): 12 people, 18.75%
- High Blood Cholesterol: 12 people, 18.75%
What are the existing conditions these people have? *
- High Blood Pressure: 14 people, 21.88%
- Hepatitis B: 12 people, 18.75%
- Hyperlipidaemia (presence of excess lipids in the blood): 12 people, 18.75%
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 12 people, 18.75%
- Paronychia (infection in the tissues adjacent to a nail on a finger or toe): 11 people, 17.19%
- Arrhythmias (irregular heartbeat): 11 people, 17.19%
- Breast Cancer Metastatic: 11 people, 17.19%
- Abdominal Pain: 11 people, 17.19%
- Musculoskeletal Pain (pain affects the bones, muscles, ligaments, tendons, and nerves): 10 people, 15.62%
- Lip Oedema (swelling of lip): 10 people, 15.62%
* Approximation only. Some reports may have incomplete information.
Do you take Methylprednisolone and have Visual field defect?
- Check whether Visual field defect is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Methylprednisolone:
- Methylprednisolone (59,645 reports)
Visual field defect treatments and more:
- Visual field defect (8,900 reports)
How severe was Visual field defect and when was it recovered:
Expand to all the drugs that have ingredients of methylprednisolone:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Methylprednisolone:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Visual field defect:
- Visual field defect (766 drugs)
Browse all the conditions that are associated with Visual field defect:
- Visual field defect (1,038 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on methylprednisolone (the active ingredients of Methylprednisolone) and Methylprednisolone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Omeprazole and Aspirin drug interactions for girls aged 2-9 - a second ago
- Could Sertraline Hydrochloride cause Pulmonary Vasculitis? - 2 seconds ago
- Losartan Potassium and Hypoaesthesia for Men aged 60+ - 25 seconds ago
- Flexeril and Catapres drug interactions for women aged 40-49 - 29 seconds ago
- Drug interactions of Ssd and Spironolactone - 32 seconds ago
- Drug interactions of Avalide and Dyazide - 46 seconds ago
- Drug interactions of Nicotine and Cipro - 47 seconds ago
- Could Dexamethasone cause Dental Fistula? - a minute ago
- Could Opdivo cause Eyelid Ptosis? - a minute ago
- Could Celecoxib cause Adrenal Insufficiency? - a minute ago